Matches in Wikidata for { <http://www.wikidata.org/entity/Q86302625> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q86302625 description "clinical trial" @default.
- Q86302625 description "ensayu clínicu" @default.
- Q86302625 description "klinisch onderzoek" @default.
- Q86302625 description "клінічне випробування" @default.
- Q86302625 description "կլինիկական փորձարկում" @default.
- Q86302625 name "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 name "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 type Item @default.
- Q86302625 label "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 label "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 prefLabel "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 prefLabel "Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer" @default.
- Q86302625 P1132 Q86302625-3CD04026-F636-4621-9038-E31C264BE013 @default.
- Q86302625 P1476 Q86302625-D7536318-B23F-4028-AE14-4E967A0A6953 @default.
- Q86302625 P17 Q86302625-6F2325BF-6AA4-4F33-A72C-C0F13A0CDC97 @default.
- Q86302625 P2899 Q86302625-4D03FCF0-9CE3-4C48-ACF7-62FE7DED24E0 @default.
- Q86302625 P3098 Q86302625-7694CA46-3EE1-454A-AE09-CB79823BC67D @default.
- Q86302625 P31 Q86302625-829AF89F-9929-4991-8755-8A678D3C9AAE @default.
- Q86302625 P4844 Q86302625-21918BB2-911B-4DF7-BDA8-B0B5969D2030 @default.
- Q86302625 P4844 Q86302625-4C079545-FFC9-4B8C-A7D7-2A533B829645 @default.
- Q86302625 P4844 Q86302625-52C5C83D-F69B-41FD-A618-F063F8D62A6E @default.
- Q86302625 P4844 Q86302625-68BC219E-918B-4FC6-B04C-1EDF02047587 @default.
- Q86302625 P580 Q86302625-5CDEC6BD-70B1-4445-B1DA-76B55E497831 @default.
- Q86302625 P582 Q86302625-73DDC018-947E-4648-8F35-6DF380DEB208 @default.
- Q86302625 P6099 Q86302625-9AED080B-FDA2-466A-8BAA-5C45F1D06243 @default.
- Q86302625 P767 Q86302625-B182798C-16A1-4A7D-AF7B-4A18A18C0D49 @default.
- Q86302625 P8363 Q86302625-25C60C11-A5FA-41E5-964B-0691BAC43FEF @default.
- Q86302625 P1132 "+41" @default.
- Q86302625 P1476 "Phase 2 Study of Platinum-Based Chemotherapy in Combination With Durvalumab (MEDI 4736) for NSCLC in Patients With a Poor Performance Status and the Elderly" @default.
- Q86302625 P17 Q30 @default.
- Q86302625 P2899 "+18" @default.
- Q86302625 P3098 "NCT04262869" @default.
- Q86302625 P31 Q30612 @default.
- Q86302625 P4844 Q19904005 @default.
- Q86302625 P4844 Q415220 @default.
- Q86302625 P4844 Q415588 @default.
- Q86302625 P4844 Q423762 @default.
- Q86302625 P580 "2020-04-01T00:00:00Z" @default.
- Q86302625 P582 "2022-01-31T00:00:00Z" @default.
- Q86302625 P6099 Q42824440 @default.
- Q86302625 P767 Q664846 @default.
- Q86302625 P8363 Q78089383 @default.